Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03193970 · ClinicalTrials.gov registry record
Measuring Surgical Recovery After Radical Cystectomy
A clinical trial of Bladder Cancer, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 11
- Study locations
NCT03193970 is a study of Bladder Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 2,000 participants, below the 12,742-participant average among 175 other Bladder Cancer trials with a reported enrollment target (84% lower). The trial reports 11 study locations across 8 states.
The verdict
NCT03193970, a study of Bladder Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 11
- Study locations
Study Summary
The intent of this study is to establish a registry of post-surgical outcomes in patients undergoing radical cystectomy at MD Anderson Cancer Center and the collaborating institutions. The goals of this initiative are to obtain a detailed baseline of multiple patient-reported outcomes (PRO) and clinician-reported outcomes (CRO) as well as various presenting conditions associated with them, so that future quality improvement interventions can be evaluated accurately as to their relative contribution to improved outcomes.
Conditions Studied
Interventions
- BEHAVIORAL Post-Operative Recovery Registry
Study Locations (11)
California
- University of California - San Francisco - San Francisco
- Stanford University - Stanford
New York
- Winthrop University Hospital - Mineola
- University of Rochester - Rochester
Texas
- University of Texas - Southwestern - Dallas
- University of Texas MD Anderson Cancer Center - Houston
Georgia
- Emory University - Atlanta
Illinois
- University of Chicago - Chicago
Kansas
- University of Kansas Medical Center - Lawrence
Maryland
- John Hopkins Medical Institutions - Baltimore
Michigan
- Spectrum Health Medical Group - Grand Rapids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2015-04-30 |
| Est. Completion | 2034-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03193970
The ClinicalTrials.gov registry entry for NCT03193970 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,742-participant average among 175 other Bladder Cancer trials with a reported enrollment target (84% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bladder Cancer appearing as the primary indexed condition, and to 1 intervention - of which Post-Operative Recovery Registry is the first listed.
NCT03193970 reports 11 study locations spanning 8 distinct geographic areas - top geographies include California, New York, Texas.
Frequently Asked Questions
What is clinical trial NCT03193970 about?
NCT03193970 is a clinical study titled "Measuring Surgical Recovery After Radical Cystectomy". The intent of this study is to establish a registry of post-surgical outcomes in patients undergoing radical cystectomy at MD Anderson Cancer Center and the collaborating institutions. The goals of this initiative are to obtain a detailed baseline of multiple patient-reported outcomes (PRO) and clin...
What is the current status of trial NCT03193970?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2015-04-30. Estimated completion is 2034-12-31.
What conditions does trial NCT03193970 study?
This clinical trial studies the following conditions: Bladder Cancer.
What interventions are being tested in trial NCT03193970?
The interventions under investigation include: Post-Operative Recovery Registry (BEHAVIORAL).
Who is sponsoring clinical trial NCT03193970?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03193970 being conducted?
This trial has 11 study locations across California, Georgia, Illinois, Kansas, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bladder Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
RECRUITING · Phase 1
-
Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
RECRUITING · NA
-
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
RECRUITING · Phase 1
-
CONFIRM: Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.